Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1912 results about "Psychiatry" patented technology

Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of mental disorders. These include various maladaptations related to mood, behaviour, cognition, and perceptions. See glossary of psychiatry.

Composition beneficial to improvement of brain cognition, memory and sleep and used for preventing and improving Alzheimer's disease

The invention provides a composition beneficial to improvement of brain cognition, memory and sleep and prevention and improvement of Alzheimer's disease, and belongs to the technical field of health food. The composition comprises L-alpha-glycerophosphorylcholine (GPC), phosphatidylserine (PS), docosahexaenoic acid (DHA), tea leaf theanine (L-theanine), vitamin B groups, vitamin D3 and the like, and is prepared into a health care product, a dietary supplement, a functional food, a medical food or a nutritional supplement by adopting the existing technology. The traditional Chinese medicine composition has the effects of effectively nourishing nerve cells, improving the brain sensitivity and improving the cognitive function. The composition is particularly directed at age-related cognitive decline and neurodegenerative diseases. Repair and regeneration of nerve cells can be promoted, the transmission efficiency of neural signals is enhanced, and the overall working efficiency of the brain is improved. Daily life challenges caused by cognitive decline can be relieved, and individual life quality can be improved.
Owner:BEIJING PUCHEN TECHNOLOGY CO LTD

Methods of treating generalized anxiety disorder

PCT designated stage expiredWO2025128594A1Nervous disorderPill deliveryOrally disintegrating tabletGeneralized anxiety
Owner:MIND MEDICINE INC

Method and system for cognitive training based on eye movement tracking control technology

The embodiment of the invention provides a cognitive training method and system based on an eye movement tracking control technology, and relates to the field of eye movement tracking, and the method comprises the steps: obtaining test data, corresponding to a plurality of eye movement test tasks, of a tested person; wherein the various eye movement test tasks comprise eye movement test tasks corresponding to each cognitive ability to be evaluated, aiming at each cognitive ability, according to eye movement test data, related to the cognitive ability, of the testee, index values of various ability evaluation indexes, corresponding to the cognitive ability, of the testee are determined; and determining the ability score corresponding to the cognitive ability, and determining a matched target cognitive training game according to the ability scores corresponding to various cognitive abilities of the testee. According to the method, the cognitive competence is evaluated based on the eye movement data of the testee, and the matched game is selected according to the evaluation result to train the cognitive competence, so that the interestingness of cognitive training is enhanced, and the training effect of cognitive training is remarkably improved.
Owner:CHENGDU JISI MINGZHI TECH CO LTD

Methods for detecting CSF tau species with stage and progression of alzheimer's disease, and use thereof

The present disclosure provides methods to quantify and analyze various CSF Tau species and the use thereof to measure pathological features and / or clinical symptoms of tauopathies, including determining the amount of time to dementia due to Alzheimer's disease, determining the time from dementia onset, staging Alzheimer's disease, guiding treatment decisions, and evaluate the clinical efficacy of certain therapeutic interventions.
Owner:WASHINGTON UNIV IN SAINT LOUIS

Intelligent intervention system for children with infantile autism spectrum disorder based on multi-modal neural feedback

PendingCN121102675ABiological modelsSensorsDecision controlEmotional arousal
The invention discloses an intelligent intervention system for children with autism spectrum disorder based on multi-modal neural feedback, which comprises a multi-modal physiological signal acquisition module for acquiring electroencephalogram signals of a target child in real time and generating an original physiological signal set; the multi-modal fusion analysis module receives the original physiological signal set and generates a comprehensive evaluation signal representing the current neurocognitive state and the emotion awakening level of the child; the self-adaptive decision control module receives the comprehensive evaluation signal and generates a self-adaptive control signal containing a neural feedback parameter adjustment instruction and a game interaction strategy instruction; the neural feedback intervention module receives the neural feedback parameter adjustment instruction and generates an adaptive neural feedback stimulation signal to act on the child; and the intelligent interactive game module receives a game interactive strategy instruction and dynamically adjusts game scene contents. The intelligent intervention system for children with autism spectrum disorder based on multi-modal neural feedback can solve the problems of poor individual adaptation of autism intervention, multi-modal data splitting and lack of dynamic adjustment.
Owner:河南脑游记信息科技有限公司

Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function

The present disclosure is directed to acetyl-leucine or a pharmaceutically acceptable salt thereof for use in improving cognitive function, mobility, or cognitive function and mobility in a subject, for example, in an elderly subject.
Owner:INTRABIO LTD

Clinical treatment scheme recommendation method based on brain diseases

The invention relates to the technical field of clinical treatment scheme recommendation. The invention relates to a clinical treatment scheme recommendation method based on brain diseases. The method comprises the following steps: S1, collecting brain examination data of a patient and other collectable body data, and then extracting disease features and other features of the brain; s2, collecting a historical clinical treatment scheme set and corresponding historical patient data, and combining the historical clinical treatment scheme set with the historical patient data to score the effect of the treatment scheme; according to the scheme adjusting model, the system can carry out personalized adjustment on the treatment scheme according to individual differences of patients, the unique characteristics of each patient are considered, the most suitable treatment scheme is customized for the patient, and meanwhile, the treatment effect of the treatment scheme is predicted by applying a simulation analysis technology; a doctor and a patient can roughly know effects possibly brought by different schemes before treatment, so that the doctor can select a scheme with a better curative effect expectation, and blind attempts are avoided.
Owner:PROSWELL MEDICAL CO

Method and apparatus for detecting stereotyped behavior to support diagnosis of autism spectrum disorder

Disclosed herein is a method for stereotyped behavior detection for supporting diagnosis of Autism Spectrum Disorder (ASD). The method includes detecting a target object to be assessed in an input video, detecting a section in which a periodic behavior occurs using an image sequence of the target object, and classifying a stereotyped behavior in the section in which the periodic behavior occurs.
Owner:ELECTRONICS & TELECOMM RES INST

Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Intranasal dry powder epinephrine compositions are described herein. The compositions include epinephrine or a pharmaceutically acceptable salt thereof, as well as a stabilizing agent and a carrier. The stabilizing agent is operable to include citric acid, or a pharmaceutically acceptable salt derived therefrom. Such intranasal compositions as described herein are useful in the treatment of health conditions which threaten the central nervous system (CNS) and impede the actions of alpha and beta-adrenergic receptors. Such health conditions include anaphylaxis, bronchospasms, respiratory impairment, organophosphate poisoning, and major adverse cardiac events (MACE).
Owner:BELHAVEN BIOPHARMA INC

Method of treating depression using seltorexant

PCT designated stage expiredWO2025003991A1Organic active ingredientsNervous disorderHepatic impairmentReduced dose
A method of treating an orexin-2 mediated disorder in a human subject in need thereof is provided. The method comprises administering seltorexant or a pharmaceutically acceptable salt or hydrate thereof at a therapeutically effective daily dose to the subject, when the subject does not have a hepatic impairment. The method also comprises administering seltorexant or the pharmaceutically acceptable salt or hydrate thereof at a reduced dose less than the daily dose to the subject, when the subject has moderate hepatic impairment.
Owner:JANSSEN PHARMA NV

Methods and kits for assessing alzheimer's disease

The disclosure relates to methods and kits for detecting tau, e.g., tau that is phosphorylated at amino acid position T181 (pTau181), tau that is phosphorylated at amino acid position T217 (pTau217), and / or total tau. The disclosure further provides methods for distinguishing between individuals whose cognitive condition will remain stable and whose cognitive condition will decline during their lifetime. The disclosure also provides methods for determining the eligibility of individuals for participation in clinical trials for Alzheimer's disease treatments. Also provided are methods for distinguishing between individuals with Alzheimer's disease and non-Alzheimer's dementia, and for monitoring response to treatment for Alzheimer's disease.
Owner:MESO SCALE TECH LLC +1

Intelligent psychological counseling system based on multi-mode large model and cognitive behavior therapy

The invention provides an intelligent psychological counseling system based on a multi-mode large model and a cognitive behavior therapy, and the system comprises the steps: recognizing voice from a user side through the multi-mode large model, and obtaining text information and emotional state information; analyzing the text information by using a large language model, carrying out conversation with the user side, and extracting psychological state information of the user side from the conversation; a cognitive behavior treatment strategy matched with the user side is determined according to the emotional state information, so that a voice response to the user side is generated according to the matched cognitive behavior treatment strategy by using a multi-mode large model; by combining a multi-modal large model and a large language model, accurate and efficient natural language understanding of a user side is realized, highly anthropomorphic voice response is provided, dependence on professional psychological consultants is reduced, limitation of psychological consultation services on time and regions can be broken through, large-scale consultation service requirements can be met in an all-weather and low-cost manner, and the psychological consultation service experience is improved. The man-machine interaction experience in the consultation process is improved, and high-quality and high-practicability psychological consultation and treatment services are provided.
Owner:BEIJING INST OF TECH

Methods of treating patients suffering from brain injury and methods of increasing the value of the extended Glasgow Outcome Scale of patients suffering from brain injury

The present invention relates to methods of treating a human patient suffering from brain injury. These method may comprise (starting) administering to a selected patient within a time period of ≤12 hours or within a time period of >12 hours after the occurrence of the brain injury a therapeutically effective amount of a biopterin compound such as 4-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin. The invention also relates to methods of increasing the value of the extended Glasgow Outcome Scale (eGOS) of patients suffering from brain injury, thereby improving the condition of the patient.
Owner:VERINOS OPERATIONS GMBH

Treatment of autism with cannabidiol

The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Owner:HARMONY BIOSCIENCES MANAGEMENT INC

Method of improving sleep

ActiveUS12427132B2Organic active ingredientsNervous disorderCircadian rhythm sleep disorderSleep wake
Owner:VANDA PHARMACEUTICALS INC

Evaluation system and method applied to cognitive disorder intervention

InactiveCN121306557AMedical data miningHealth-index calculationIntervention evaluationClinical staff
The invention belongs to the technical field of cognitive impairment intervention evaluation, and particularly relates to an evaluation system and method applied to cognitive impairment intervention. According to the method, the cognitive state is evaluated and the training tasks are allocated based on the real data of the user in the natural life scene, so that the one-sidedness of only depending on a laboratory or one-time evaluation is avoided, the training and intervention are closer to the real demand and life situation of the user, and the training efficiency is improved through multi-source data fusion. The influence of single signal noise or accidental fluctuation on judgment is reduced, the robustness and objectivity of evaluation are improved, indexes such as cognitive performance, intervention indexes and deviation degree are numeralized, long-term tracking and transverse comparison of the effects of different intervention measures are facilitated, interpretable quantitative evidences are provided for clinical personnel, and the accuracy of evaluation is improved. Intervention indexes are calculated in real time, intervention measures are automatically adjusted or reselected according to feedback results, and a quick-response closed-loop system is formed, so that the time from problem discovery to effective intervention is shortened, and the intervention conversion rate is increased.
Owner:THE FIRST AFFILIATED HOSPITAL OF XIAN MEDICAL UNIV

Medical system for diagnosing cognitive disease pathology and / or outcome

A medical system useful in the determination of future disease progression in a subject. More specifically the present invention applies machine learning techniques to aid prediction of disease pathology and clinical outcomes in subjects presenting with symptoms of cognitive decline and to expedite clinical development of novel therapeutics.
Owner:GE HEALTHCARE LTD

Child restraint system

The present disclosure relates to child restraint systems and components of child restraint systems, for example child seats like a toddler seat and an infant seat, support bases of child seats, in particular support bases that are fixable on a vehicle seat and which bases may be an integral part of a child seat or which may be configured such that a child seat is releasably couplable to them.
Owner:THULE SWEDEN AB

System and method of relapse prediction and addiction treatment support using a neural network

Methods and systems for predicting addiction relapse risk in a patient include; receiving patient data of a patient; predicting, by a trained neural network model, based on the patient data, an addiction relapse risk in the patient; generating a recommendation based on the predicted addiction relapse risk; and communicating the recommendation to a relevant party.
Owner:SENSEI AI LTD

Prodrugs of itaconate and methyl itaconate

Prodrugs of itaconic acid and 1- and 4-methyl itaconic acid and their use for treating a disease, disorder, or condition associated with inflammation are disclosed.
Owner:INST OF ORGANIC CHEM & BIOCHEMISTRY OF THE ACAD OF SCI OF THE CZECH REPUBLIC +1

Treatment of autism with cannabidiol

The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Owner:HARMONY BIOSCIENCES MANAGEMENT INC

Therapeutic use of p75NTR neurotrophin binding protein

PendingUS20250177485A1Senses disorderNervous disorderNeurotrophin bindingPsychiatry
The present invention relates to a p75NTR neurotrophin binding protein, p75NTR (NBP), for use in the treatment of pain and / or a symptom of pain.
Owner:LEVICEPT LTD

Detection reagent for detecting depression by sugar chain marker, preparation method and application

The invention provides a detection reagent for detecting depression based on an oligosaccharide chain and a preparation method and application thereof, the detection reagent is prepared by mixing the following reagents: a reagent A, which is prepared by adding SDS with the mass concentration of 1-5% into an ammonium bicarbonate solution with the concentration of 10mM and the pH value of 8.3; the reagent B is prepared by mixing 0.05-10 units / 10 microliters of glycosamine acylase, NP-40 with the mass concentration of 10% and an ammonium bicarbonate solution with the concentration of 10 mM and the pH value of 8.3, and the pH value of the mixed solution is 5-9; the reagent C is an organic matter reducing agent with the concentration of 0.02 mM to 1M, which is prepared by dissolving 8-aminopyrene-1, 3, 6-trisulfonic acid in DMSO (Dimethylsulfoxide); and a reagent D: a stop solution. The invention firstly proposes that the sugar chain map can be used as the auxiliary diagnosis marker of the depression patient, has high sensitivity and high specificity for the diagnosis of depression, has the prospect of being developed into a clinical auxiliary diagnosis kit for depression, can overcome the difficulty and pain point of clinical diagnosis of depression at present, and has a wide application prospect. The method is of great significance to diagnosis and clinical intervention of depression.
Owner:JIANGSU XIANSIDA BIOTECH CO LTD +1

Microbial signatures of autism spectrum disorder

Aspects of the disclosure relate to methods and compositions for diagnosing and / or treating subjects having one or more symptoms of Autism Spectrum Disorder (ASD) or subjects at risk of developing ASD. In some embodiments, methods comprise determining and / or modulating levels of chorismate and / or a molecule within a chorismate metabolic pathway in a subject. In some embodiments, methods comprise determining and / or modulating levels of a microbial feature (e.g., a Sarcina bacterium) in a subject. In some embodiments, methods comprise determining and / or modulating levels of proton flux in a gastrointestinal tract in a subject.
Owner:PITON THERAPEUTICS INC

A system and method for assisting the development of an adult-child attachment relationship

A system is provided for assisting the development of an adult-child attachment relationship. One or more child physiological or behavioral signals are sensed for the adult and the child. An adult-child activity is chosen by the system and an association between the adult and child signals is analyzed so as to estimate a level of synchrony between the adult and child associated with the selected adult-child activity. An output is generated which depends on the level of synchrony.
Owner:KONINKLIJKE PHILIPS NV